Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab

Name: Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab
Published: 2011
License: Public Domain

Memorial Sloan Kettering Cancer Center · 2011

ClinicalTrials.gov · Datasets · License: Public Domain · 2011

Open Source ↗

leukemia

leukemia, 19-28z retrovirus, cyclophosphamide (cytoxan), autologous t cells, leukapheresis, 11-048, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab

Related documents